References
- Krbec AC. Current understanding and management of hidradenitis suppurativa. J. Am. Acad. Nurs. Pract.19(5), 228–234 (2007).
- Wiseman M. Hidradenitis suppurativa: a review. Dermatol. Ther.17(1), 50–54 (2004).
- Plewig G, Kligman AM. Acne: Morphogenesis and Treatment. Springer-Verlag, Berlin, Germany (1975).
- Scheinfeld N. Hidradenitis should not be renamed acne inversa. Dermatol. Online J.12(7), 6 (2006).
- Bazex J, Bayle P, San B. Hidradenitis suppurativa is acne inversa. Int. J. Dermatol.46(3), 330 (2007).
- von der Werth JM, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br. J. Dermatol.144(4), 809–813 (2001).
- Jemec GB, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J. Am. Acad. Dermatol.35(2 Pt 1), 191–194 (1996).
- Jemec GBE. Medical treatment of hidradenitis suppurativa. Expert Opin. Pharmacother.5(8), 1767–1770 (2004).
- Revuz JE, Canoui-Poitrine F, Wolkenstein P et al. Prevalence and factors associated with hidradenitis suppurativa: results form two case–control studies. J. Am. Acad. Dermatol.59(4), 695–601 (2008).
- Slade DEM, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br. J. Plast. Surg.56(5), 451–461 (2003).
- Wolkenstein P, Loundou A, Barrau K, Auquier P, Revuz J. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. J. Am. Acad. Dermatol.56(4), 621–623 (2007).
- Kurzen H, Kurokawa I, Jemec GBE et al. What causes hidradenitis suppurativa? Exp. Dermatol.17(5), 455–472 (2008).
- Brook I, Frazier H. Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J. Med. Microbiol.48(1), 103–105 (1999).
- Sartorius K, Lapins J, Jalal S, Emtestam L, Hedberg M. Bacteraemia in patients with hidradenitis suppurativa undergoing carbon dioxide laser surgery: detection and quantification of bacteria by lysis-filtration. Dermatology213(4), 305–312 (2006).
- Jemec GBE, Hansen U. The histology of hidradenitis suppurativa. J. Am. Acad. Dermatol.34(6), 994–999 (1996).
- Jemec GBE, Thomsen BM, Hansen U. The homogeneity of hidradenitis suppurativa lesions. A histological study of intraindividual variation. APMIS105(5), 378–383 (1997).
- Gniadecki R, Jemec GBE. Lipid raft-enriched CD29+ keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp. Dermatol.13(6), 361–363 (2004).
- Gao M, Wang P, Cui Y et al. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p.21.1–1q25.3. J. Invest. Dermatol.126(6), 1302–1306 (2006).
- Lapins J, Olerup O, Emtestam L. No human leukocyte antigen-A, -B or -DR association in Swedish patients with hidradenitis suppurativa. Acta Derm. Venereol.81(1), 28–30 (2001).
- Barth JH, Kealey T. Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa. Br. J. Dermatol.125(4), 304–308 (1991).
- Barth JH, Layton AM, Cunliffe WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br. J. Dermatol.134(6), 1057–1059 (1996).
- Arnadottir M, Jonsson E, Jonsson J. Inactivity of hidradenitis suppurativa after renal transplantation. Transplantation82(6), 849 (2006).
- Lapins J, Asman B, Gustafsson A, Bergström K, Emtestam L. Neutrophil-related host response in hidradenitis suppurativa: a pilot study in patients with inactive disease. Acta Derm. Venereol.81(2), 96–99 (2001).
- Giamarellos-Bourboulis EJ, Antonopoulou A, Petropoulou C et al. Altered innate and adaptive immune responses in patients with hidradenitis suppurativa. Br. J. Dermatol.156(1), 51–56 (2007).
- Ather S, Chan D, Leaper D, Harding K. Surgical treatment of hidradenitis suppurativa: case series and review of the literature. Int. Wound J.3(3), 159–169 (2006).
- Sartorius K, Lapins J, Emstestam L, Jemec GBE. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br. J. Dermatol.149(1), 211–213 (2003).
- Shah N. Hidradenitis suppurativa: a treatment challenge. Am. Fam. Physician72(8), 1547–1552 (2005).
- Traczewski P, Rudnicka L. Adalimumab in dermatology. Br. J. Clin. Pharmacol.66(5), 618–625 (2008).
- Mendonça CO, Griffiths CEM. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br. J. Dermatol.154(5), 977–978 (2006).
- Friedel D, Climo M. Nasal colonization with methicillin-resistant Staphylococcus aureus: clinical implications and treatment. Curr. Infect. Dis. Rep.9(3), 201–207 (2007).
- Jemec GBE. Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clin. Exp. Dermatol.27(6), 528–529 (2002).
- Joseph MA, Jayaseeelan E, Ganapathi B, Stephen J. Hidradenitis suppurativa treated with finasteride. J. Dermatol. Treat.16(2), 75–78 (2005).
- Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolaevullinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br. J. Dermatol.152(4), 803–804 (2005).
- Kaur MR, Lewis HM. Hidradenitis suppurativa treated with daspone: a case series of five patients. J. Dermatol. Treat.17(4), 211–213 (2006).
- Kagan RJ, Yakuboff KP, Warner P, Warden GD. Surgical treatment of hidradenitis suppurativa: a 10-year experience. Surgery138(4), 734–741 (2005).
- Lapins J, Sartorius K, Emtestam L. Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J. Am. Acad. Dermatol.47(2), 280–285 (2002).
- Fardet l, Dupuy A, Kerob D et al. Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients. J. Am. Acad. Dermatol.56(4), 624–628 (2007).
- Brunaso AMG, Delfino C, Massone C. Hidradenitis suppurativa: are tumour necrosis factor-α blockers the ultimate alternative? Br. J. Dermatol.159(3), 761–763 (2008).
- Sullivan TP, Welsh E, Kerdel FA, Burdick AE, Kirsner RS. Infliximab for hidradenitis suppurativa. Br. J. Dermatol.149(5), 1046–1049 (2003).
- Usmani N, Clayton TH, Everett S, Goodfield DJ. Variable response of hidradenitis suppurativa to infliximab in four patients. Clin. Exp. Dermatol.32(2), 204–205 (2007).
- Thielen AM, Barde C, Saurat JH. Long-term infliximab for severe hidradenitis suppurativa. Br. J. Dermatol.154(5), 1105–1108 (2006).
- Adams D, Gordon K, Devenyi A, Ioffreda M. Severe hidradenitis suppurativa treated with infliximab infusion. Arch. Dermatol.139(12), 1540–1542 (2007).
- Lebwohl B, Sapadin A. Infliximab for the treatment of hidradenitis suppurativa. J. Am. Acad. Dermatol.49(5), S275–S276 (2003).
- Moul D, Korman N. The cutting edge. Severe hidradenitis suppurativa treated with adalimubab. Arch. Dermatol.142(9), 1110–1112 (2006).
- Scheinfeld N. Treatment of coincident seronegative arthritis and hidradenitis suppurativa with adalimimab. J. Am. Acad. Dermatol.55(1), 163–164 (2006).
- Cusack C, Buckley C. Etanercept: effective in the management of hidradenitis. Br. J. Dermatol.154(4), 726–729 (2006).
- Mekkes JR, Bos JD. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa. Br. J. Dermatol.158(2), 370–374 (2008).
- Giamarellos-Bourboulis EJ, Pelekanou A, Antonopoulou A et al. An open-label Phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa. Br. J. Dermatol.158(3), 567–572 (2008).
- Striber BE, Kim C, Siu K. Efalizumab for the therapy of refractory hidradenitis suppurativa. J. Am. Acad. Dermatol.57(6), 1090–1091 (2007).
- Lapins J, Ye W, Nyren O, Emtestam L. Incidence of cancer among patients with hidradenitia suppurativa. Arch. Dermatol.137(6), 730–734 (2001).
- Rosenzweig L, Brett A, Lefaivre J, Vandersteenhoven JJ. Hidradenitis suppurativa complicated by squamous cell carcinoma and paraneoplastic neuropathy. Am. J. Med. Sci.329(3), 150–152 (2005).
Website
- Hidradenitis Information Development and Exchange www.hs-foundation.org/index.html